馬來酸丙氯拉嗪市場（依適應症、劑型、通路、最終用戶及地區分類）

Prochlorperazine Maleate Market, By Indication, By Dosage Form, By Distribution Channel, By End User, By Geography

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2025 年馬來酸丙氯拉嗪市場規模為 16.1 億美元，到 2032 年將達到 20.3 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 3.4%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	16.1億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年年複合成長率：	3.40%	2032年價值預測	20.3億美元

馬來酸丙氯拉嗪用於治療嚴重的噁心和嘔吐，並改善思覺失調症和焦慮症患者的情緒、思維和行為。它屬於吩噻嗪類藥物。此藥物的作用機轉是影響腦部化學反應。因此，身體可能會產生更多的多巴胺，這是一種有助於運動和愉悅感的神經傳導物質。它也可能掩蓋導致噁心和嘔吐的更嚴重的疾病，例如藥物過量攝取或中毒、腦腫瘤、腦損傷和雷氏症候群。吩噻嗪類抗精神病藥物之一是馬來酸丙氯拉嗪。

市場動態：

預測期內，嘔吐和噁心頻率的增加將繼續推動全球馬來酸丙氯拉嗪市場的成長。由於慢性病發病率上升和人口老化，需要止吐治療的人數正在增加。此外，患者意識的提高也將持續推動全球馬來酸丙氯拉嗪市場的成長。患者正在尋找合適的替代療法，並更積極地與醫療保健提供者討論相關問題。聯合治療的出現可能會在預測期內為全球馬來酸丙氯拉嗪市場創造新的機會。對含有馬來酸丙氯拉嗪的複方藥物進行分析，具有市場成長的潛力。

預計在預測期內，安全問題和負面副作用將阻礙全球馬來酸丙氯拉嗪市場的成長。

本報告的主要特點

本報告對全球馬來酸丙氯拉嗪市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和年複合成長率。
它還強調了每個細分市場的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球馬來酸丙氯拉嗪市場的主要企業根據以下參數列出，例如公司概況、產品系列、主要亮點、財務表現和策略。
透過本報告的見解，負責人和企業經營團隊可以就未來的產品發布、合作夥伴關係、市場擴張和行銷策略做出明智的決策。
「全球馬來酸丙氯拉嗪市場」報告涉及該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球馬來酸丙氯拉嗪市場的各種策略矩陣輕鬆做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 1.61 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	3.40%	2032 Value Projection:	USD 2.03 Bn

Prochlorperazine maleate is utilized for treating severe nausea and vomiting as well as to help people with schizophrenia or anxiety have better moods, thinking, and conduct. It is a member of the phenothiazine class of drugs. The way this drug affects brain chemistry is how it functions. Dopamine, a neurotransmitter that aids in movement and pleasure, might then be produced in greater amounts by the body as a result. It can also mask more serious illnesses that produce nausea and vomiting, such as drug overdose or poisoning, brain tumors, brain injuries, or Reye's syndrome. A medicine from the phenothiazine class of antipsychotics is called prochlorperazine maleate.

Market Dynamics:

The increasing frequency of vomiting and nausea will continue to fuel growth of the global prochlorperazine maleate market over the forecast period. The number of people requiring antiemetic therapy is rising as a result of rising chronic disease prevalence and an aging population. Growing patient awareness will also continue to fuel growth of the global prochlorperazine maleate market over the forecast period. Patients are more active in seeking out the right therapy alternatives and talking about their issues with medical providers. The creation of combination therapies will create new opportunities for the global prochlorperazine maleate market over the forecast period. There is potential for market growth in the investigation of combination medicines containing prochlorperazine maleate.

Safety issues and negative side effects are expected to hamper growth of the global prochlorperazine maleate market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the global prochlorperazine maleate market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global prochlorperazine maleate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline plc, Pfizer Inc., Novartis AG, AstraZeneca plc, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sanofi S.A., Johnson & Johnson, AbbVie Inc., Eli Lilly and Company, Merck & Co., Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Lupin Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global prochlorperazine maleate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prochlorperazine maleate market

Global Prochlorperazine Maleate Market Detailed Segmentation:

By Indication:
- Nausea and Vomiting Management
- Vertigo
- Mental Health Disorders (e.g., Schizophrenia)
By Dosage Form:
- Oral Tablets
- Rectal Suppositories
- Injectable Formulations
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By End User:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Homecare Settings
By Regions:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profile:
- GlaxoSmithKline plc
- Pfizer Inc.
- Novartis AG
- AstraZeneca plc
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Sanofi S.A.
- Johnson & Johnson
- AbbVie Inc.
- Eli Lilly and Company
- Merck & Co., Inc.
- Bristol-Myers Squibb Company
- Boehringer Ingelheim International GmbH
- Sun Pharmaceutical Industries Ltd.
- Lupin Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Pu rview

Report Description
- Market Definition and Scope
Executive Summary
- Market Prochlorperazine Maleate, By Indication
- Market Prochlorperazine Maleate, By Dosage Form
- Market Prochlorperazine Maleate, By Distribution Channel
- Market Prochlorperazine Maleate, By End User
- Market Prochlorperazine Maleate, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Prochlorperazine Maleate Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Prochlorperazine Maleate Market , By Indication, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Nausea and Vomiting Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Vertigo
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Motion Sickness
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Prochlorperazine Maleate Market , By Dosage Form, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Rectal Suppositories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Injectable Formulations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Prochlorperazine Maleate Market, By Distribution Channel, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Prochlorperazine Maleate Market , By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.K.
  - Germany
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - China
  - Japan
  - India
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2020-2032,(US$ Bn)
North Africa
South Africa
Central Africa

9. Competitive Landscape

Sandoz Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mylan Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
ABneal Pharmaceuticals LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Glenmark Pharmaceuticals Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sun Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Aurobindo Pharma Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Aspen Pharma Trading Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
FAGRON
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GlaxoSmithKline
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Hikma Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views